Alcohol Consumption and Circulating Metabolites

NCT03402568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2974

Last updated 2018-01-23

No results posted yet for this study

Summary

Alcohol consumption is a risk factor for numerous health conditions and an important cause of death. Identifying metabolites associated with alcohol consumption may provide insights into the metabolic pathways through which alcohol may affect human health. The objective of this study is to investigate associations of alcohol consumption with circulating concentrations of 123 metabolites including amino acids, acylcarnitines, hexoses, biogenic amines, phosphatidylcholines, and sphingomyelins. For this purpose, the investigators use data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study and applied a discovery and replication approach.

Conditions

  • No Condition, Focus: Metabolites of Alcohol Consumption

Sponsors & Collaborators

  • Maastricht University

    collaborator OTHER
  • Imperial College London

    collaborator OTHER
  • Danish Cancer Society

    collaborator OTHER
  • University of Aarhus

    collaborator OTHER
  • Centre for Research in Epidemiology and Population Health (CESP)

    collaborator OTHER
  • Gustave Roussy, Cancer Campus, Grand Paris

    collaborator OTHER
  • German Cancer Research Center

    collaborator OTHER
  • German Institute of Human Nutrition

    collaborator OTHER
  • Hellenic Health Foundation

    collaborator OTHER
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER
  • ISPO Cancer Prevention and Research Institute

    collaborator UNKNOWN
  • Federico II University

    collaborator OTHER
  • HuGeF Foundation

    collaborator UNKNOWN
  • Azienda Sanitaria Provinciale Ragusa

    collaborator OTHER
  • University of Tromso

    collaborator OTHER
  • Institut Català d'Oncologia

    collaborator OTHER
  • Ministry of Health - Government of the Principality of Asturias

    collaborator OTHER_GOV
  • Andalusian School of Public Health

    collaborator OTHER_GOV
  • Universidad de Murcia

    collaborator OTHER
  • Instituto de Salud Pública Gobierno de Navarra

    collaborator UNKNOWN
  • Subdirección de Salud Pública de Gipuzkoa

    collaborator UNKNOWN
  • Skane University Hospital

    collaborator OTHER
  • Umeå University

    collaborator OTHER
  • MORGEN-EPIC, Bilthoven

    collaborator UNKNOWN
  • Prospect-EPIC, Utrecht

    collaborator UNKNOWN
  • University of Oxford

    collaborator OTHER
  • University of Cambridge

    collaborator OTHER
  • International Agency for Research on Cancer

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-24
Primary Completion
2016-10-26
Completion
2016-10-26

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03402568 on ClinicalTrials.gov